Steven M. Bair

NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

Jonathan D. Brown, Charles Y. Lin, Qiong Duan et al. · Molecular Cell · 2014 · 614 citations · Full text

Inflammation, Inflammatory Disease, Immunology +7

SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer

Lianjie Li, Chuan Shen, Eijiro Nakamura et al. · Cancer Cell · 2013 · 163 citations · Full text

Urology, Genitourinary Cancer, Medicine +10

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas

Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg et al. · Haematologica · 2020 · 51 citations · Full text

Immunology, Pathology, Metronomic Chemotherapy +18

Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy

Nicole A. Carreau, Orrin Pail, Philippe Armand et al. · The Oncologist · 2020 · 46 citations · Full text

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Geoffrey Shouse, Andy Kaempf, Max J. Gordon et al. · Blood Advances · 2023 · 44 citations · Full text

Prognosis, Immunology, Pathology +19